CAJ | 학술논문

新生血管性青光眼（ neovascular glaucoma，NVG）是一种破坏性强、失明率高的顽固性眼病。病因复杂，发病机制尚不十分清楚。目前的治疗方式主要有药物、激光和手术治疗，青光眼引流阀植入联合玻璃体注射抗新生血管药物成为新的治疗趋势。本文就NVG的病因，发病机制，诊断及治疗做一综述。
신생혈관성청광안（ neovascular glaucoma，NVG）시일충파배성강、실명솔고적완고성안병。병인복잡，발병궤제상불십분청초。목전적치료방식주요유약물、격광화수술치료，청광안인류벌식입연합파리체주사항신생혈관약물성위신적치료추세。본문취NVG적병인，발병궤제，진단급치료주일종술。
Neovascular glaucoma ( NVG) is an intractable, highly destructive eye disease.NVG is associated with high rate of blindness.The pathogenesis of NVG has not yet well understood.Currently, glaucoma drainage implant surgery combined with anti-vascular endothelial growth factor treatment is the favorable management for NVG.Conventional thera-pies included tropical medication, laser, and surgeries.This review focuses on the progress in researches that lead to better understanding of its pathogenesis, early diagnosis, improved management, and prognosis.